Invention Grant
- Patent Title: Synthesis of tipifarnib
-
Application No.: US17056745Application Date: 2019-05-17
-
Publication No.: US11542244B2Publication Date: 2023-01-03
- Inventor: Pingda Ren , Xiaohu Deng , Wanping Mai
- Applicant: KURA ONCOLOGY, INC.
- Applicant Address: US CA San Diego
- Assignee: KURA ONCOLOGY, INC.
- Current Assignee: KURA ONCOLOGY, INC.
- Current Assignee Address: US CA San Diego
- Agency: Jones Day
- International Application: PCT/US2019/032765 WO 20190517
- International Announcement: WO2019/222565 WO 20191121
- Main IPC: C07D401/06
- IPC: C07D401/06
Abstract:
Provided herein are methods of preparing a desired enantiomer 6-[amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl) methyl]-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone, otherwise known as tipifarnib.
Public/Granted literature
- US20210246114A1 SYNTHESIS OF TIPIFARNIB Public/Granted day:2021-08-12
Information query
